Stock BLPH BELLEROPHON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Bellerophon Therapeutics, Inc.

Equities

BLPH

US0787713009

Delayed OTC Markets
Other stock markets
 02:10:41 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.0554 USD +0.73% Intraday chart for Bellerophon Therapeutics, Inc. +1.84% +49.73%
Apr. 25 North American Morning Briefing : More Tech -2- DJ
Apr. 11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ

Evolution of the average Target Price on Bellerophon Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f.gFa0e5ffxXit9Dwiy9LC2z5mA9kYPeYDAor8CkB52bQ.uQzxE8Gz8hT6g05LhbWti1wHWZ98C6gzeM-NZSEU7czXe9cO9ZLwDtqnTw~e964ab70e3295d034dd024970f2f9f4d

Analyst Recommendations on Bellerophon Therapeutics, Inc.

North American Morning Briefing : More Tech -2- DJ
North American Morning Briefing : Stocks Futures Steady on Rates Optimism DJ
HC Wainwright Adjusts Bellerophon Therapeutics Price Target to $2 From $30, Maintains Buy Rating MT
Brookline Capital Downgrades Bellerophon Therapeutics to Hold From Buy MT
Laidlaw Downgrades Bellerophon Therapeutics to Hold From Buy MT
Laidlaw Initiates Bellerophon Therapeutics at Buy With $35 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.0554
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Bellerophon Therapeutics, Inc.

HC Wainwright
Laidlaw & Co.
Brookline Capital Markets

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BLPH Stock
  4. Consensus Bellerophon Therapeutics, Inc.